Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study.

Larocca Alessandra
First
;
Bringhen Sara;Mina Roberto;Magarotto Valeria;Boccadoro Mario;Palumbo Antonio
Last
2013-01-01

2013
122
16
2799
2806
https://ashpublications.org/blood/article/122/16/2799/31781/Pomalidomide-cyclophosphamide-and-prednisone-for
https://doi.org/10.1182/blood-2013-03-488676
Larocca Alessandra;Montefusco Vittorio;Bringhen Sara;Rossi D;Crippa C;Mina Roberto;Galli M;Marcatti M;La Verde G;Giuliani N;Magarotto Valeria;Guglielmelli Tommasina;Rota-Scalabrini Delia;Omedé Paola;Santagostino A;Baldi I;Carella AM;Boccadoro Mario;Corradini P;Palumbo Antonio
File in questo prodotto:
File Dimensione Formato  
PCP_Revision 5 August 2013_First Edition.pdf

Accesso aperto

Descrizione: Author's version. Larocca A, Montefusco V, Bringhen S, Rossi D, Crippa C, Mina R, Galli M, Marcatti M, La Verde G, Giuliani N, Magarotto V, Guglielmelli T, Rota-Scalabrini D, Omedé P, Santagostino A, Baldi I, Carella AM, Boccadoro M, Corradini P, Palumbo A. Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study. Blood. 2013 Oct 17;122(16):2799-806. doi: 10.1182/blood-2013-03-488676. Epub 2013 Aug 16. PMID: 23954889. © 2013 by The American Society of Hematology. The published version is avaialble at: https://ashpublications.org/blood/article/122/16/2799/31781/Pomalidomide-cyclophosphamide-and-prednisone-for | https://doi.org/10.1182/blood-2013-03-488676. When citing, please refer to the published version.
Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 759.38 kB
Formato Adobe PDF
759.38 kB Adobe PDF Visualizza/Apri
[Published Vsn and Suppl Appendix] Larocca et al - 2013 - Blood - PCP RRMM.pdf

Accesso riservato

Descrizione: Restricted access - Published version. Larocca A, Montefusco V, Bringhen S, Rossi D, Crippa C, Mina R, Galli M, Marcatti M, La Verde G, Giuliani N, Magarotto V, Guglielmelli T, Rota-Scalabrini D, Omedé P, Santagostino A, Baldi I, Carella AM, Boccadoro M, Corradini P, Palumbo A. Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study. Blood. 2013 Oct 17;122(16):2799-806. doi: 10.1182/blood-2013-03-488676. Epub 2013 Aug 16. PMID: 23954889. © 2013 by The American Society of Hematology. The published version is avaialble at: https://ashpublications.org/blood/article/122/16/2799/31781/Pomalidomide-cyclophosphamide-and-prednisone-for | https://doi.org/10.1182/blood-2013-03-488676
Tipo di file: PDF EDITORIALE
Dimensione 856.38 kB
Formato Adobe PDF
856.38 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/148803
Citazioni
  • ???jsp.display-item.citation.pmc??? 27
  • Scopus 81
  • ???jsp.display-item.citation.isi??? 73
social impact